The maintenance of genomic stability during the cell cycle of progenitor cells is essential for the faithful transmission of genetic information. Mutations in genes that ensure genome stability lead to human developmental syndromes. Mutations in Ataxia Telangiectasia and Rad3-related (ATR) or in ATR-interacting protein (ATRIP) lead to Seckel syndrome, which is characterized by developmental malformations and short life expectancy. While the roles of ATR in replicative stress response and chromosomal segregation are well established, it is unknown how ATRIP contributes to maintaining genomic stability in progenitor cells in vivo. Here, we generated the first mouse model to investigate ATRIP function. Conditional inactivation of Atrip in progenitor cells of the CNS and eye led to microcephaly, microphthalmia and postnatal lethality. To understand the mechanisms underlying these malformations, we used lens progenitor cells as a model and found that ATRIP loss promotes replicative stress and TP53-dependent cell death.
Introduction
Genomic stability is crucial for cellular and tissue homeostasis, normal development, and the prevention of tumorigenesis and aging. Mutations in genes that ensure genome stability and proper chromosomal segregation lead to human developmental syndromes 1, 2 . DNA damage response (DDR) pathways sense, signal and repair different types of DNA damage and are crucial for maintaining genomic stability 3 . The Ataxia Telangiectasia and Rad3-related (ATR) kinase regulates replication fork firing and stability to ensure the proper timing of DNA replication during S-phase and cell cycle checkpoints to prevent mitosis in cells with underreplicated DNA 4, 5 . When single-stranded DNA (ssDNA) is exposed at DNA damage sites or replication forks, RPA-coated ssDNA recruits ATR-interacting protein (ATRIP) and activates ATR, which coordinates a replicative stress response (RSR) 6, 7 . ATR protein stability and activity as well as all the described functions of ATR depend on ATRIP 6, 8 .
In humans, mutations in ATR or ATRIP lead to Seckel syndrome, which is characterized by growth defects, neurodevelopmental malformations and short life expectancy 1 . Mouse models of ATR loss of function have highlighted the essential contribution of ATR to development. While Atr germline inactivation leads to early embryonic lethality 9, 10 , conditional knockout mice have revealed that ATR plays essential roles in proper cell cycle progression, genome stability and meiosis 11, 12, 13, 14 .
In addition, hypomorphic Atr mutations in mice recapitulate some of the developmental defects observed in Seckel syndrome patients 15 . Although the contribution of ATR to genomic stability and appropriate development has been extensively investigated, the function of ATRIP in vivo is unknown.
The accumulation of DNA damage can activate the tumor suppressor protein TP53, a master regulator of the DDR that regulates cell cycle arrest, apoptosis, cell metabolism and DNA repair 16, 17 . Moreover, inactivation of DDR-related genes may lead to TP53-dependent apoptosis 17, 18 . Notably, Atr inactivation increases spontaneous DNA damage, but the simultaneous inactivation of Atr and Trp53 in mouse neural progenitor cells (NPCs) does not rescue brain growth defects 12, 19 . Additionally, TP53-inactivated cancer cells are particularly sensitive to ATR signaling inhibition 20, 21, 22 , suggesting that ATR and TP53 work in parallel to prevent DNA damage accumulation. Indeed, Trp53 inactivation in hypomorphic Atr-mutated mice leads to synthetic lethality 15 . This evidence suggests cooperation between the ATRIP-ATR signaling pathway and Trp53; however, the synergy between these pathways during the cell cycle progression of unchallenged progenitor cells is not completely understood.
Here, we developed a new mouse model to investigate the function of ATRIP. We showed that the tissue-specific inactivation of Atrip during CNS and eye development led to severe growth defects that were associated with the death of progenitor cells. Next, due to its well-characterized developmental kinetics and cell cycle dynamics 23 , we used the developing lens as a model to better understand the cellular and molecular outcomes of Atrip inactivation in vivo. Importantly, the developing lens was particularly useful for probing the cross-talk between Trp53 and other tumor suppressor genes 24 . Atrip inactivation led to replicative stress, DNA damage accumulation and TP53-dependent apoptosis. Interestingly, while Trp53 inactivation rescued the apoptosis of Atrip-deficient lens progenitor cells, it increased mitotic defects and did not rescue the observed microphthalmia. Taken together, these results reveal essential roles of ATRIP for DNA damage avoidance and progenitor cell homeostasis during development.
Materials and Methods

Mice
The experimental procedures involving animals were approved by the Committee of Ethics in Animal Use of the Health Science Center (CEUA/CCS) of Brazil and approved by the governmental review board of Baden-Württemberg, Germany (Regierungspräsidium Karlsruhe-Abteilung 3-Landwirtschaft, Ländlicher Raum, Veterinär-und Lebensmittelwesen).
The generation of Atrip Flox mice was performed as follows. The targeting vector was constructed using the recombineering method developed by the National Cancer Institute (USA). The BAC containing Atrip was obtained from the Wellcome Trust Sanger Institute (bMQ-176B24). Exons 1, 2 and 3 of Atrip were targeted since the deletion of these exons was predicted to abrogate protein translation. One LoxP site was inserted upstream of exon 1, and the pGK-neo cassette flanked by two Frt sites followed by a second LoxP was inserted between exons 3 and 4. Prior to E14.1 ES cell electroporation, the targeting vector was linearized (NotI), and proper targeting was verified by restriction mapping and sequencing. After 12 days, 384 individual clones were analyzed by Southern blotting (with EcoRI digestion and a genomic probe), and 15 clones 
RNA extraction, cDNA synthesis and real-time RT-PCR
Lenses from three different mice of the same litter were dissected in cold PBS and lysed in 1 mL of TRIzol (Life/Thermo Fisher, Cat# 15596026), and RNA extraction was performed as previously described 25 . 
Volume measurements of the eye
The volumes of postnatal and adult eyes were measured as previously described 26 .
Histology and immunofluorescence
Histological analyses were performed in cryosections. Embryo heads were fixed in 4% PBS-buffered paraformaldehyde for 24 hours at 4 °C and cryoprotected in 10, 20
and 30% (overnight) PBS-buffered sucrose solutions. Sections of 10 μm were obtained using a Leica 1850 cryostat.
Slides were washed with PBS, and antigen retrieval was performed using citrate buffer (pH=6). The following antibodies and dilutions were used: anti- To label S-phase cells in vivo, intraperitoneal injections of 50 μg/g of body weight of BrdU (Sigma Aldrich, cat# B5002) were performed. Embryos were collected 1 hour after injection. TUNEL analysis was performed following the manufacturer's instructions (Promega, cat# G7362). Fluorescent images were captured using a Leica TCS-SP5 with an AOBS system.
Western blot analysis
Protein extraction and SDS-PAGE protein separation were performed as previously reported 27 . Primary antibodies for the following target proteins were used: ATR (1:500, Santa Cruz Biotechnology, cat# SC1887) and α-tubulin (1:10000, Santa
Cruz, cat #: sc32293). HRP-conjugated secondary antibodies from Cell Signaling were employed (1:1000, anti-mouse IgG, cat #: 7076, anti-rabbit IgG, cat #: 7074). The ECL system (cat #: RPN2132) was used according to the manufacturer's instructions, and chemiluminescence was captured using ChemiDoc MP (BioRad) equipment.
Statistical analysis
GraphPad Prism software was used for statistical analysis. The t-test, one-way ANOVA and two-way ANOVA were performed as indicated. The reported p-values are based on two-sided tests.
Results
ATRIP loss in the eye and CNS causes microcephaly, microphthalmia and premature lethality
To understand the function of ATRIP in vivo, we generated an Atrip conditional knockout mouse in which the first three exons of the Atrip gene were flanked by LoxP sequences (Atrip Lox ) ( Figure 1a ). Three Atrip-targeted ES cell clones verified by Southern blotting were injected into blastocysts, and 12 chimeras with a high percentage of chimerism were obtained. Germline transmission was confirmed by Southern blotting and PCR (Figure 1b and c). To inactivate Atrip in the developing CNS and eye, we generated
Nestin-Cre; Atrip Lox/Lox mice (Atrip Nes-Cre ). We confirmed genomic recombination by PCR ( Figure 1d ) and decreased Atrip mRNA expression by real-time RT-PCR ( Figure 1e ).
Interestingly, no difference in Atr mRNA levels was detected in the cortex of Atrip Nes-Cre mice at E17.5 (Figure 1e ), but a decrease in the ATR protein content was evident ( Figure   1f ). These data indicate that, as previously described in cell lines 8, 28 , ATRIP is essential for ATR protein stability in NPCs in vivo.
The inactivation of Atrip in the CNS and eye did not change the Mendelian ratio at birth in the mice; however, Atrip Nes-Cre mice showed a reduced body mass ( Figure 2a) and died around P9. Additionally, Atrip Nes-Cre mice exhibited microcephaly and microphthalmia (Figure 2b and d ). Histological analysis of P7 brains revealed profound developmental growth impairment of the cerebellum, hippocampus and dorsal striatum ( Figure 2c ). Notably, these phenotypes mirror the developmental defects observed in mice with an ATR-deficient CNS 12 .
ATRIP is essential for lens development
To understand the function of ATRIP in vivo, we decided to focus our analysis on lens development. This tissue is a unique model for analyzing cell cycle dynamics in vivo 
ATRIP loss induces cell death of lens progenitor cells
To investigate how ATRIP loss affects the maturation stages of lens development, we analyzed the morphology, cell proliferation and cell death of Atrip Nes-Cre lenses.
Nestin-Cre-mediated recombination occurs around E12.5-E13.5 in lens progenitor cells 29 . At this developmental stage, the lens anterior epithelium is composed of cells that proliferate and migrate towards the equatorial region, where they exit the cell cycle and differentiate to form fiber cells 30, 31 (Figure 3a ( Figure 3e ). In addition, no change in the proportion of mitotic cells, as revealed by phospho-histone H3 (pH3) staining, was observed in Atrip-deficient progenitors ( Figure   3f ). These findings suggest that the ATRIP-ATR signaling pathway is key to preventing DNA damage accumulation and apoptosis in progenitor cells.
Cell death induced by Atrip inactivation is TP53 dependent
DNA damage induces the stabilization of TRP53 and TRP53-mediated cell death (Meek, 2009 ). We asked whether the observed accumulation of DNA damage in Atripdeficient lens progenitor cells leads to TRP53 stabilization and/or TRP53-mediated cell death. Immunostaining for total TRP53 revealed its stabilization in Atrip-deficient lens progenitor cells (Figure 4a ). The phosphorylation of TRP53 (human S15/mouse S18) by PI3K-like kinases such as ATM and ATR is a well-characterized mechanism of TRP53 stabilization 32, 33 . Consistent with the absence of TRP53 staining in control progenitor cells and with a phosphorylation-dependent stabilization of TRP53, phospho-TRP53+ progenitor cells were exclusively found in the Atrip Nes-Cre lens (Figure 4b ).
In a number of cell types and species, TRP53 stabilization following DNA damage often results in TRP53-dependent cell cycle arrest and/or apoptosis (Meek, 2009 (Figure 5a and b ), suggesting that TRP53 does not alter cell cycle progression following ATRIP loss. In contrast, as verified by the TUNEL assay ( Figure 5c ) and cCasp3 staining (Figure 5d ), the inactivation of Trp53 prevented the cell death induced by ATRIP loss in the E15.5 lens. We conclude that the apoptosis observed in embryonic Atrip-deficient lens progenitor cells is TRP53 dependent.
Simultaneous inactivation of Atrip and Trp53 induces mitotic defects
To test whether the simultaneous inactivation of Atrip and Trp53 affects the DDR in progenitor cells, we scored the proportion of γH2AX+ cells. Interestingly, even though (Figure 6c ).
Finally, we tested whether the increase in DDR activation is correlated with the accumulation of mitotic defects (bridges, multiple spindle pole formation and fragmented chromosomes). In the control lens, only ~1.5% of mitotic cells presented defects, while ~5% of mitotic cells exhibited defects following Atrip inactivation. Remarkably, a much higher proportion of mitotic cells (~15%) presented defects in the cDKO lens epithelium ( Figure 6d ). Altogether, these findings suggest that in the absence of TRP53, some Atripdeficient lens progenitor cells may escape the S/M checkpoint, enter mitosis, accumulate more DNA damage and eventually die during mitosis. Accordingly, double pH3 and TUNEL staining revealed apoptotic cells during mitosis in the cDKO lens at E15.5 ( Figure 6e ). Interestingly, although the concomitant inactivation of Atrip and Trp53 reverted apoptosis induced by ATRIP loss, the eye volume of cKO and cDKO mice was similar at P7. This finding demonstrates that Trp53 inactivation is not sufficient to rescue the eye growth impairment caused by ATRIP deficiency (Figure 6f ). We conclude that, although TRP53 is able to rescue cell death, double inactivation of Atrip and Trp53 increases mitotic defects and does not rescue eye growth defects observed after Atrip inactivation.
Discussion
Our data demonstrate that ATRIP is essential for CNS and eye development. We showed that ATRIP protected progenitor cells from endogenous DNA damage. We found that a few days after Cre-mediated Atrip inactivation (~3 days, at E15. Tissue growth defects are one of the main characteristics of Seckel syndrome patients, including facial dysmorphisms, microcephaly and ophthalmological defects 35, 36, 37, 38 . Prior to our study, there was a lack of data supporting the idea that ATRIP could play a role during development. Here, we report the first mouse model of ATRIP loss of function. Atrip inactivation in the CNS and eye led to developmental growth impairment, including microcephaly, mirroring those associated with ATR loss 12 . Moreover, Atrip inactivation decreased the ATR protein content, establishing a direct connection between ATRIP and ATR function in vivo. In summary, the role of ATRIP during development supports its relationship with Seckel syndrome etiology.
In the absence of ATRIP function, we observed increased activation of the DDR, as revealed by γH2AX and phospho-TRP53 staining. Following DSB formation, both ATM and DNA-PK are able to phosphorylate these targets 32, 39, 40 . Although we did not determine which kinase was activated following ATRIP loss, our findings are consistent with the formation of DSBs and activation of ATM or DNA-PK or both. Nevertheless, it was shown that even of absence of the three main DDR kinases (ATM, ATR and DNA-PK), γH2AX phosphorylation and TRP53 activation are still detected, therefore we cannot exclude alternative pathways 41 .
The depletion of the ATRIP-ATR complex was shown to increase underreplicated DNA, causing the accumulation of mitotic defects 4, 42 therefore, it is possible that the presence of underreplicated DNA during S-phase leads to the mitotic defects observed in Atrip-deficient lens progenitor cells. In this scenario, Atrip and Trp53 double inactivation would increase the number of cells that are able to reach mitosis with underreplicated DNA, inducing a further increase in progenitors with mitotic defects. However, we cannot exclude the possibility of mitotic-specific roles of the ATRIP-ATR complex and TRP53.
In fact, recent findings indicate that ATR is important for proper chromosomal segregation in cell lines 5, 34 . Further studies are necessary to investigate the cell cycle phase-specific contributions of ATRIP -ATR and TRP53 during unchallenged replication in vivo.
Atr inactivation compromises the development of the cerebellum, which is associated with the accumulation of mitotic defects 12, 19 . Interestingly, in contrast to what we observed in the developing lens, Trp53 inactivation did not rescue the cell death or the increase in mitotic DNA damage induced by ATR loss in cerebellar progenitor cells 19 . On the other hand, it was shown that TP53-deficient chronic lymphocytic leukemia (CLL) cells displayed an increase in mitotic defects after ATR inhibition 43 . In addition, the accumulation of mitotic defects following ATR inactivation was also shown in transformed cell lines 44 . These data indicate that ATRIP-ATR inactivation may have different outcomes depending on the cell type and genetic background. Since the ATRIP-ATR pathway is activated by replicative stress, we hypothesize that the levels of endogenous replicative stress may be at least partly responsible for these cell type-specific effects.
Currently, different ATR inhibitors are being successfully implemented in preclinical and clinical trials as monotherapy or in combination with other DNAdamaging drugs 45, 46 , highlighting the relevance of studying the roles of the ATRIP-ATR 
